FDA Inspection 1269545 - Imran S. Khawaja, M.D. - May 06, 2025

Record Details

This FDA Inspection record concerns Imran S. Khawaja, M.D., with an inspection on May 6, 2025, issued by the Dallas District Office, covering human drugs.

Company: Imran S. Khawaja, M.D.
Inspection Date: May 6, 2025
Product Type: Human Drugs
Office: Dallas District Office

Open in Dashboard

ID · 5b3d1b0f-0fa9-4a5c-8cbb-b32b92cd4614

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.